(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

Oct 25, 2017 7:00 AM - Oct 27, 2017 3:00 PM

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

DIA/FDA Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

Back to Agenda

Breakfast Plenary Session: Emergency Single Patient IND for Oligonucleotide Therapy of a Unique Individual Mutation: A Case Study in Batten's Disease

Session Chair(s)

Arthur M. Krieg, MD

Arthur M. Krieg, MD

CEO and CSO

Checkmate Pharmaceuticals, United States

Breakfast Plenary Session: Emergency Single Patient IND for Oligonucleotide Therapy of a Unique Individual Mutation: A Case Study in Batten's Disease

Speaker(s)

Timothy W. Yu, MD, PhD

Speaker

Timothy W. Yu, MD, PhD

Boston Children’s Hospital, United States

Associate Professor, Harvard Medical School; Division of Genetics and Genomics

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.